BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28088700)

  • 1. Chlorogenic acid ameliorated concanavalin A-induced hepatitis by suppression of Toll-like receptor 4 signaling in mice.
    Yuan Y; Gong X; Zhang L; Jiang R; Yang J; Wang B; Wan J
    Int Immunopharmacol; 2017 Mar; 44():97-104. PubMed ID: 28088700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paeoniflorin protects against concanavalin A-induced hepatitis in mice.
    Chen M; Cao L; Luo Y; Feng X; Sun L; Wen M; Peng S
    Int Immunopharmacol; 2015 Jan; 24(1):42-9. PubMed ID: 25479726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emodin protects against concanavalin A-induced hepatitis in mice through inhibiting activation of the p38 MAPK-NF-κB signaling pathway.
    Xue J; Chen F; Wang J; Wu S; Zheng M; Zhu H; Liu Y; He J; Chen Z
    Cell Physiol Biochem; 2015; 35(4):1557-70. PubMed ID: 25792514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of ellagic acid on concanavalin A-induced hepatitis via toll-like receptor and mitogen-activated protein kinase/nuclear factor κB signaling pathways.
    Lee JH; Won JH; Choi JM; Cha HH; Jang YJ; Park S; Kim HG; Kim HC; Kim DK
    J Agric Food Chem; 2014 Oct; 62(41):10110-7. PubMed ID: 25238033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protectin D1 reduces concanavalin A-induced liver injury by inhibiting NF-κB-mediated CX3CL1/CX3CR1 axis and NLR family, pyrin domain containing 3 inflammasome activation.
    Ren J; Meng S; Yan B; Yu J; Liu J
    Mol Med Rep; 2016 Apr; 13(4):3627-38. PubMed ID: 26955849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorogenic Acid Attenuates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting TLR4/NF-κB Signal Pathway.
    Ye HY; Jin J; Jin LW; Chen Y; Zhou ZH; Li ZY
    Inflammation; 2017 Apr; 40(2):523-529. PubMed ID: 28028753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1.
    Jaruga B; Hong F; Kim WH; Gao B
    Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G1044-52. PubMed ID: 15246962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway.
    Shi H; Dong L; Jiang J; Zhao J; Zhao G; Dang X; Lu X; Jia M
    Toxicology; 2013 Jan; 303():107-14. PubMed ID: 23146752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic detoxification of chlorogenic acid against acetaminophen-induced liver injury by ameliorating hepatic inflammation.
    Zheng Z; Sheng Y; Lu B; Ji L
    Chem Biol Interact; 2015 Aug; 238():93-101. PubMed ID: 26079055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin attenuates Concanavalin A-induced liver injury in mice by inhibition of Toll-like receptor (TLR) 2, TLR4 and TLR9 expression.
    Tu CT; Han B; Yao QY; Zhang YA; Liu HC; Zhang SC
    Int Immunopharmacol; 2012 Jan; 12(1):151-7. PubMed ID: 22138522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorogenic acid attenuates lipopolysaccharide-induced mice mastitis by suppressing TLR4-mediated NF-κB signaling pathway.
    Ruifeng G; Yunhe F; Zhengkai W; Ershun Z; Yimeng L; Minjun Y; Xiaojing S; Zhengtao Y; Naisheng Z
    Eur J Pharmacol; 2014 Apr; 729():54-8. PubMed ID: 24457123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmenter of liver regeneration (ALR) restrains concanavalin A-induced hepatitis in mice.
    Mu M; Zhang Z; Cheng Y; Liu G; Chen X; Wu X; Zhuang C; Liu B; Kong X; You S
    Int Immunopharmacol; 2016 Jun; 35():280-286. PubMed ID: 27085679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in mice.
    Nakashima H; Kinoshita M; Nakashima M; Habu Y; Shono S; Uchida T; Shinomiya N; Seki S
    Hepatology; 2008 Dec; 48(6):1979-88. PubMed ID: 18942689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emodin ameliorated lipopolysaccharide-induced fulminant hepatic failure by blockade of TLR4/MD2 complex expression in D-galactosamine-sensitized mice.
    Yin X; Gong X; Jiang R; Kuang G; Wang B; Zhang L; Xu G; Wan J
    Int Immunopharmacol; 2014 Nov; 23(1):66-72. PubMed ID: 25173984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG ODN pretreatment attenuates concanavalin A-induced hepatitis in mice.
    Zhang H; Gong Q; Li JH; Kong XL; Tian L; Duan LH; Tong J; Song FF; Fang M; Zheng F; Xiong P; Tan Z; Gong FL
    Int Immunopharmacol; 2010 Jan; 10(1):79-85. PubMed ID: 19818415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sesamin ameliorates lipopolysaccharide/d-galactosamine-induced fulminant hepatic failure by suppression of Toll-like receptor 4 signaling in mice.
    Ma L; Gong X; Kuang G; Jiang R; Chen R; Wan J
    Biochem Biophys Res Commun; 2015 May; 461(2):230-6. PubMed ID: 25866179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury.
    Wang J; Sun R; Wei H; Dong Z; Tian Z
    Int Immunopharmacol; 2006 May; 6(5):800-7. PubMed ID: 16546711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1--relevance for concanavalin A-induced hepatitis.
    Wolf D; Hallmann R; Sass G; Sixt M; Küsters S; Fregien B; Trautwein C; Tiegs G
    J Immunol; 2001 Jan; 166(2):1300-7. PubMed ID: 11145713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of lactate and β-hydroxybutyrate in the treatment of concanavalin-A induced hepatitis.
    Hazem SH; Hamed MF; Saad MA; Gameil NM
    Int Immunopharmacol; 2018 Aug; 61():376-384. PubMed ID: 29945025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice.
    Kato J; Okamoto T; Motoyama H; Uchiyama R; Kirchhofer D; Van Rooijen N; Enomoto H; Nishiguchi S; Kawada N; Fujimoto J; Tsutsui H
    Hepatology; 2013 Jan; 57(1):362-72. PubMed ID: 22936459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.